Off-treatment responses and predictors and after long-term anti-HBV therapy with nucleos(t)ide analogues
10.3760/cma.j.issn.1007-3418.2017.07.003
- VernacularTitle: 核苷（酸）类似物长期抗HBV治疗停药后应答情况及其预测因素
- Author:
Youde LIU
1
;
Lei WANG
2
Author Information
1. Department of Hepatology, Yantai Infectious Diseases Hospital, Yantai, Shandong Province 264001, China
2. Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, Jinan 250033, China
- Publication Type:Journal Article
- Keywords:
Hepatitis B, chronic;
Nucleos(t)ide analogues;
Off-treatment;
Predictors
- From:
Chinese Journal of Hepatology
2017;25(7):490-494
- CountryChina
- Language:Chinese
-
Abstract:
Recurrence rate after cessation of nucleos(t)ide analogues remains high in clinical practice. According to current evidences, age, HBsAg level, HB VRNA level, time of consolidation therapy and HBV DNA load were considered to be associated with off-treatment responses after cessation of nucleos(t)ide analogues. Combinative factors of several predictors might perform better in future accompanying with further studies of HBV related markers.
